No Data
No Data
Market Chatter: Expanded Indication for GSK, Pfizer RSV Vaccines Faces Government Review
Moderna, Pharma Stocks Fall as FDA Names Industry Critic as Top Vaccine Regulator -- Barrons.com
Unusual Options Activity: MAT, KR and Others Attract Market Bets, MAT V/OI Ratio Reaches 110.9
India Offers US Reciprocal Zero Tariffs on Steel, Auto Parts, Pharmaceutical Drugs, Bloomberg Reports
GSK Declares $0.4216 Dividend
GlaxoSmithKline (GSK) Gets a Hold From Barclays
frankinglily : GSK's specialty growth sounds promising.![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
Shaaaw : Mixed analyst ratings have me cautious.